BACKGROUND: Cervical total disc replacement (CTDR) is complicated by adjacent segment degeneration (ASD). Since non-physiological spine kinematics after CTDR was postulated to cause ASD, M6-C prosthesis has been developed to better replicate the natural kinematics of the intervertebral disc. This retrospective cohort study aims to compare the short-term outcomes between patients receiving either the M6-C or Mobi-C prostheses. METHODS: Patients who had refractory radiculopathy and/or myelopathy secondary to cervical degenerative disc disease and underwent CTDR between March 2004 and April 2017 were included. All CTDRs were performed by a single surgeon at a single institution. Self-reported clinical outcomes and radiological parameters were evaluated at baseline and final follow-up between March 2004 and April 2018. RESULTS: Sixty-two patients with greater than 1-year follow-up or who developed HO within 12 months of surgery, were included in the study. The mean radiological follow-up was 29.0 months (3-84 months), which includes 7 patients with less than 12 months follow-up who also developed HO. The changes in clinical and radiological measures were comparable between M6-C and Mobi-C prostheses. Thirty-seven out of 52 spinal segments (71.2%) and 10 out of 16 spinal segments (62.5%) developed HO in M6-C and Mobi-C group respectively. There was no significant difference in the rate of HO between the two groups. CONCLUSIONS: No short-term differences were found in clinical or radiological outcomes between patients who received either the M6-C or Mobi-C prosthesis. Further randomized trials with a long-term follow-up period are warranted to determine the safety and efficacy of M6-C prosthesis. 2019 Journal of Spine Surgery. All rights reserved.
BACKGROUND: Cervical total disc replacement (CTDR) is complicated by adjacent segment degeneration (ASD). Since non-physiological spine kinematics after CTDR was postulated to cause ASD, M6-C prosthesis has been developed to better replicate the natural kinematics of the intervertebral disc. This retrospective cohort study aims to compare the short-term outcomes between patients receiving either the M6-C or Mobi-C prostheses. METHODS: Patients who had refractory radiculopathy and/or myelopathy secondary to cervical degenerative disc disease and underwent CTDR between March 2004 and April 2017 were included. All CTDRs were performed by a single surgeon at a single institution. Self-reported clinical outcomes and radiological parameters were evaluated at baseline and final follow-up between March 2004 and April 2018. RESULTS: Sixty-two patients with greater than 1-year follow-up or who developed HO within 12 months of surgery, were included in the study. The mean radiological follow-up was 29.0 months (3-84 months), which includes 7 patients with less than 12 months follow-up who also developed HO. The changes in clinical and radiological measures were comparable between M6-C and Mobi-C prostheses. Thirty-seven out of 52 spinal segments (71.2%) and 10 out of 16 spinal segments (62.5%) developed HO in M6-C and Mobi-C group respectively. There was no significant difference in the rate of HO between the two groups. CONCLUSIONS: No short-term differences were found in clinical or radiological outcomes between patients who received either the M6-C or Mobi-C prosthesis. Further randomized trials with a long-term follow-up period are warranted to determine the safety and efficacy of M6-C prosthesis. 2019 Journal of Spine Surgery. All rights reserved.
Authors: Jason C Eck; S Craig Humphreys; Tae-Hong Lim; Soon Tack Jeong; Jesse G Kim; Scott D Hodges; Howard S An Journal: Spine (Phila Pa 1976) Date: 2002-11-15 Impact factor: 3.468
Authors: A G Patwardhan; M N Tzermiadianos; P P Tsitsopoulos; L I Voronov; S M Renner; M L Reo; G Carandang; K Ritter-Lang; R M Havey Journal: Eur Spine J Date: 2010-09-24 Impact factor: 3.134
Authors: John G Heller; Rick C Sasso; Stephen M Papadopoulos; Paul A Anderson; Richard G Fessler; Robert J Hacker; Domagoj Coric; Joseph C Cauthen; Daniel K Riew Journal: Spine (Phila Pa 1976) Date: 2009-01-15 Impact factor: 3.468
Authors: Ian J Wellington; Cameron Kia; Ergin Coskun; Barrett B Torre; Christopher L Antonacci; Michael R Mancini; John P Connors; Sean M Esmende; Heeren S Makanji Journal: Bioengineering (Basel) Date: 2022-05-23